You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

elagolix

Showing 1 - 25 of 37
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Endometriosis Trial in Beijing (Elagolix, Elagolix )

Recruiting
  • Endometriosis
  • Elagolix
  • Elagolix placebo
  • Beijing, Beijing, China
    Peking University First Hospital
Oct 6, 2023

Endometriosis Trial in Beijing (Elagolix, Elagolix )

Recruiting
  • Endometriosis
  • Elagolix
  • Elagolix placebo
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Dec 11, 2022

Endometriosis, Unexplained Infertility Trial in Winston-Salem (Elagolix, Oral Contraceptive)

Recruiting
  • Endometriosis
  • Unexplained Infertility
  • Elagolix
  • Oral Contraceptive
  • Winston-Salem, North Carolina
    Wake Forest Univesity Health Sciences
Dec 1, 2022

Infertility, Endometriosis Trial in Lone Tree (Elagolix 200 MG, Leuprolide Acetate 3.75 MG/ML, Lab work)

Recruiting
  • Infertility
  • Endometriosis
  • Elagolix 200 MG
  • +2 more
  • Lone Tree, Colorado
    Colorado Center for Reproductive Medicine
Jul 20, 2022

Pregnancy Outcomes in Females Treated With Oral Elagolix Tablets

Recruiting
  • Endometriosis
  • Uterine Fibrioids
    • Durham, North Carolina
      Iqvia /Id# 240918
    Mar 8, 2022

    Oral Elagolix Tablets To Assess Tolerability and Change in

    Recruiting
    • Endometriosis
      • Ramat Gan, Tel-Aviv, Israel
      • +7 more
      Jun 8, 2022

      Hair in Adult Participants Taking Oral Oriahnn Capsules With

      Not yet recruiting
      • Uterine Fibroids (UF)
        • (no location specified)
        Sep 22, 2023

        Endometriosis Trial (Elagolix)

        Completed
        Has Results
        • Endometriosis
        • Elagolix
        • (no location specified)
        Jul 9, 2021

        Endometriosis Trial (Elagolix)

        Completed
        Has Results
        • Endometriosis
        • Elagolix
        • (no location specified)
        Jul 9, 2021

        Heavy Uterine Bleeding, Uterine Fibroids Trial (Elagolix, Placebo, Estradiol/Norethindrone acetate (E2/NETA))

        Completed
        Has Results
        • Heavy Uterine Bleeding
        • Uterine Fibroids
        • Elagolix
        • +4 more
        • (no location specified)
        Jul 9, 2021

        Myomectomy vs Uterine Artery Embolization vs GnRh Antagonist for

        Active, not recruiting
        • Heavy Menstrual Bleeding
        • Fibroid Uterus
        • Groups 1 and 2 myomectomy and uterine artery embolization, respectively, are surgical/procedure
        • Elagolix Oral Product
        • Washington, District of Columbia
          MedStar Washington Hospital Center
        Apr 29, 2022

        Elagolix For the Treatment of Endometriosis in Canada

        Completed
        • Endometriosis
          • Calgary, Alberta, Canada
          • +17 more
          Sep 26, 2022

          Assess Patient-Reported Quality of Life and Effectiveness on

          Recruiting
          • Heavy Menstrual Bleeding
          • Uterine Fibroids
            • Durham, North Carolina
              IQVIA RDS, Inc
            Nov 2, 2021

            Uterine Fibroids Trial in Puerto Rico, United States (Elagolix, Placebo)

            Completed
            Has Results
            • Uterine Fibroids
            • Elagolix
            • Placebo
            • Birmingham, Alabama
            • +47 more
            Mar 4, 2022

            Polycystic Ovary Syndrome Trial in Puerto Rico, United States (Elagolix, Placebo)

            Completed
            Has Results
            • Polycystic Ovary Syndrome
            • Elagolix
            • Placebo
            • Birmingham, Alabama
            • +53 more
            May 16, 2022

            Infertility, Endometriosis Trial in United States (Elagolix 200 MG, Placebo or SOC IVF)

            Recruiting
            • Infertility
            • Endometriosis
            • Elagolix 200 MG
            • Placebo
            • Aurora, Colorado
            • +4 more
            Mar 15, 2022

            Heavy Uterine Bleeding, Uterine Fibroids Trial (Elagolix , Elagolix, 0.5 mg estradiol / 0.1 mg norethindrone acetate)

            Completed
            Has Results
            • Heavy Uterine Bleeding
            • Uterine Fibroids
            • Elagolix placebo
            • +4 more
            • (no location specified)
            Jul 7, 2020

            Endometriosis Trial in Puerto Rico, United States (Elagolix, Combined Oral Contraceptive (COC), Placebo for Elagolix)

            Recruiting
            • Endometriosis
            • Elagolix
            • +3 more
            • Anniston, Alabama
            • +182 more
            Jan 17, 2023

            Uterine Fibroids, Heavy Menstrual Bleeding Trial in Canada, United States (Elagolix, Placebo for Estradiol/Norethindrone

            Completed
            Has Results
            • Uterine Fibroids
            • Heavy Menstrual Bleeding
            • Elagolix
            • +3 more
            • Birmingham, Alabama
            • +104 more
            Jul 9, 2021

            Endometriosis Trial in Worldwide (BAY1817080, Elagolix, Placebo)

            Completed
            • Endometriosis
            • Birmingham, Alabama
            • +141 more
            Jun 17, 2022

            Heavy Menstrual Bleeding, Uterine Fibroids Trial in Puerto Rico, United States (Elagolix Placebo, E2/NETA, E2/NETA Placebo)

            Active, not recruiting
            • Heavy Menstrual Bleeding
            • Uterine Fibroids
            • Elagolix Placebo
            • +3 more
            • Birmingham, Alabama
            • +156 more
            Jan 20, 2022

            Endometriosis Trial in Canada, Puerto Rico, United States (Estradiol/Norethindrone Acetate, Placebo for Elagolix, Elagolix)

            Active, not recruiting
            Has Results
            • Endometriosis
            • Estradiol/Norethindrone Acetate
            • +3 more
            • Birmingham, Alabama
            • +196 more
            Feb 14, 2022

            Uterine Fibroids, Heavy Menstrual Bleeding Trial in Canada, Puerto Rico, United States (Estradiol/Norethindrone Acetate,

            Completed
            Has Results
            • Uterine Fibroids
            • Heavy Menstrual Bleeding
            • Estradiol/Norethindrone Acetate
            • Elagolix
            • Birmingham, Alabama
            • +123 more
            Jul 9, 2021

            Uterine Fibroids, Heavy Menstrual Bleeding Trial in Canada, Puerto Rico, United States (Elagolix, Placebo for

            Completed
            Has Results
            • Uterine Fibroids
            • Heavy Menstrual Bleeding
            • Elagolix
            • +3 more
            • Birmingham, Alabama
            • +95 more
            Jun 9, 2020

            Endometriosis Trial in United States (elagolix, estradiol/norethindrone acetate (E2/NETA))

            Terminated
            Has Results
            • Endometriosis
            • elagolix
            • estradiol/norethindrone acetate (E2/NETA)
            • Anniston, Alabama
            • +36 more
            Nov 8, 2019